INFLUENZA A
Clinical trials for INFLUENZA A explained in plain language.
Never miss a new study
Get alerted when new INFLUENZA A trials appear
Sign up with your email to follow new studies for INFLUENZA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New flu pill shows promise in early human safety trial
Disease control CompletedThis early-stage study tested a new pill called CC-42344 in 80 healthy adults to see if it is safe and how the body processes it. The drug works by blocking the influenza A virus from making copies of itself. The main goal was to check for side effects and measure drug levels in …
Matched conditions: INFLUENZA A
Phase: PHASE1 • Sponsor: Cocrystal Pharma, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New At-Home test aims to detect three respiratory viruses at once
Diagnosis CompletedThis study checked if a new rapid test can correctly detect Flu A, Flu B, COVID-19, and RSV from a nasal swab. Over 1,100 people with respiratory symptoms provided samples, which were compared to standard lab tests. The goal was to see how accurate the test is for over-the-counte…
Matched conditions: INFLUENZA A
Sponsor: iHealth Labs inc • Aim: Diagnosis
Last updated May 17, 2026 11:45 UTC
-
New rapid test for COVID and flu put to the test
Diagnosis CompletedThis study checked how well a new rapid test (iHealth COVID-19/Flu A&B) can detect COVID-19 and flu A&B in people with respiratory symptoms. 588 people with two or more symptoms (like fever, cough, or sore throat) gave nose swabs for the test and a standard lab test. The goal was…
Matched conditions: INFLUENZA A
Sponsor: iHealth Labs inc • Aim: Diagnosis
Last updated May 11, 2026 20:53 UTC
-
New flu drug shows promise in kids – phase 2 trial complete
Symptom relief CompletedThis study tested an experimental flu medicine called ZSP1273 in 72 children aged 2 to 17 with influenza A. Researchers measured how the drug moves through the body, checked for side effects, and tracked how quickly flu symptoms went away. The goal was to see if the drug is safe …
Matched conditions: INFLUENZA A
Phase: PHASE2 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Symptom relief
Last updated Apr 26, 2026 20:01 UTC
-
Flu vaccine Face-Off: 2023 vs 2024 shots tested in new study
Knowledge-focused CompletedThis study looked at how well the 2023 and 2024 seasonal flu vaccines work by giving the 2023 shot to a small group of adults in late spring 2024. Researchers compared their immune responses to those who got the 2023 shot in fall 2023 and those who will get the 2024 shot in fall …
Matched conditions: INFLUENZA A
Phase: PHASE4 • Sponsor: La Jolla Institute for Immunology • Aim: Knowledge-focused
Last updated May 17, 2026 11:48 UTC
-
Hidden threat: deadly fungus strikes flu patients in ICU
Knowledge-focused CompletedThis study looked at over 500 adults in intensive care with severe influenza A to understand how often they also get a serious fungal lung infection called aspergillosis. Researchers reviewed medical records from 20 hospitals in China to find risk factors and track survival rates…
Matched conditions: INFLUENZA A
Sponsor: Jianfeng Xie • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC